Johnson & Johnson has recalled 12 million bottles of its Motrin pain-reliever medicine from stores in the U.S., according to news reports.
The recall was not prompted by safety concerns, but rather that "there may be a delay in experiencing relief," according to a statement from Motrin.
The statement explained:
McNeil is recalling these products because testing of product samples showed that some caplets may not dissolve as quickly as intended when nearing their expiration date. Out of an abundance of caution, we are recalling all the listed products since there is a chance they could experience a similar problem as they approach expiration.
Motrin from stores in Puerto Rico, Bahamas, St. Lucia, Beliza and Jamaica are also included in the recall. The kinds of recalled Motrin include: Motrin IB 24-count coated caplets, Motrion IB 24-count coated tablets and Motrin IB 24+6 count coated caplets.
The Wall Street Journal reported other recent Johnson & Johnson recalls, including a recall of 2.5 million packages of Tylenol Cold Multi-Symptom Nighttime Rapid Release Gelcaps because of increased levels of a compound, as well as 60,912 Extra-Strength Tylenol bottles because of a strange, non-toxic odor coming from the medicine.
[Flickr/Wikimedia] photo by RogueSun Media.